Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • REGN10597 Alone or with Cemiplimab in Adults with Advanced Solid Tumours, Melanoma, or Clear-Cell Renal-Cell Carcinoma

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    France Germany Italy Spain
  • Long-term follow-up study of fianlimab and cemiplimab combination treatment in adult patients with melanoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Ireland
  • Study of Pembrolizumab for Patients with High-Risk Stage IIB/IIC Melanoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on Nivolumab Dose Optimization for Patients with Melanoma or Renal Cell Carcinoma Showing Complete, Partial, or Stable Response

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Melanoma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Belgium France Germany Ireland Italy +3
  • Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Belgium France Germany Ireland Italy +3
  • A Study of Lifileucel with Cyclophosphamide, Fludarabine, and Aldesleukin for Adults with Previously Treated Advanced Melanoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    France Germany Italy Spain
  • Study of Acasunlimab Alone and Combined With Pembrolizumab in Patients With Advanced Skin Melanoma That Returned or Did Not Respond to Prior Treatment

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    France Germany The Netherlands Spain
  • Study on the Use of Indocyanine Green and Technetium (99mTc) Nanocolloid for Sentinel Node Biopsy in Patients with Melanoma, Oral Cancer, or Penile Cancer

    Not recruiting

    2 1 1 1
    The Netherlands
  • Study of BT-001 and Pembrolizumab for Patients with Advanced Solid Tumors, Including Sarcoma, Merkel Cell Carcinoma, Melanoma, Breast, and Lung Cancer

    Not recruiting

    2 1 1 1
    Belgium France